Halozyme Therapeutics (HALO) News Today $54.05 +0.21 (+0.39%) Closing price 07/3/2025 03:44 PM EasternExtended Trading$54.05 0.00 (0.00%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HALO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Moody Aldrich Partners LLC Has $6.17 Million Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 4 at 6:43 AM | marketbeat.comHALO - Halozyme Therapeutics Inc Valuation - MorningstarJuly 3 at 6:51 PM | morningstar.comMMeritage Portfolio Management Buys Shares of 101,651 Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 3 at 8:07 AM | marketbeat.comNovem Group Acquires 4,821 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 3 at 6:28 AM | marketbeat.comOppenheimer & Co. Inc. Takes $625,000 Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 1, 2025 | marketbeat.comZacks Research Has Pessimistic Outlook of HALO Q1 EarningsJuly 1, 2025 | americanbankingnews.comHalozyme Therapeutics Added to Russell 1000® IndexJune 30, 2025 | prnewswire.comZacks Research Issues Pessimistic Forecast for HALO EarningsJune 30, 2025 | marketbeat.comArtemis Investment Management LLP Purchases Shares of 125,652 Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 28, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Acquired by Spire Wealth ManagementJune 28, 2025 | marketbeat.comHalozyme Therapeutics Inc (RV7.SG)June 26, 2025 | uk.finance.yahoo.comVictory Diversified Stock Fund Q1 2025 CommentaryJune 26, 2025 | seekingalpha.comEnvestnet Portfolio Solutions Inc. Has $721,000 Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 26, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Sells $1,059,200.00 in StockJune 25, 2025 | insidertrades.comHelen Torley Sells 20,000 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) StockJune 24, 2025 | marketbeat.comRetirement Systems of Alabama Has $24.54 Million Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 21, 2025 | marketbeat.comargenx gets EU nod for Vyvgart subcutaneous injectionJune 20, 2025 | msn.comHalozyme Announces argenx Received European Commission Approval for VYVGART® Subcutaneous Injection with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)June 20, 2025 | prnewswire.comBoston Trust Walden Corp Cuts Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 19, 2025 | marketbeat.comJanney Montgomery Scott LLC Grows Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 19, 2025 | marketbeat.comRoman Butler Fullerton & Co. Invests $414,000 in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 18, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Purchased by Farther Finance Advisors LLCJune 18, 2025 | marketbeat.comSG Americas Securities LLC Has $1.71 Million Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 16, 2025 | marketbeat.comElevation Point Wealth Partners LLC Acquires 7,263 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 15, 2025 | marketbeat.comCurbstone Financial Management Corp Makes New $526,000 Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 12, 2025 | marketbeat.comHandelsbanken Fonder AB Sells 250,400 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 12, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Receives Consensus Rating of "Hold" from AnalystsJune 12, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Stock Holdings Lessened by Redhawk Wealth Advisors Inc.June 11, 2025 | marketbeat.comTealwood Asset Management Inc. Sells 33,458 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 7, 2025 | marketbeat.comCongress Asset Management Co. Raises Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 7, 2025 | marketbeat.com5,900 Shares in Halozyme Therapeutics, Inc. (NASDAQ:HALO) Purchased by Two Sigma Advisers LPJune 7, 2025 | marketbeat.comRhumbline Advisers Purchases 6,922 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 6, 2025 | marketbeat.comWellington Management Group LLP Sells 7,787 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 6, 2025 | marketbeat.comMerck dispute with Halozyme over Keytruda injection to get another USPTO lookJune 4, 2025 | msn.comMeridian Growth Fund Trimmed Halozyme Therapeutics (HALO) for the Valuation DisciplineJune 4, 2025 | insidermonkey.comPGR institution likely weakens Halozyme bull case scenario, says Wells FargoJune 4, 2025 | finance.yahoo.comMeridian Growth Fund Trimmed Halozyme Therapeutics (HALO) for the Valuation DisciplineJune 4, 2025 | msn.comHalozyme Therapeutics (NASDAQ:HALO) Stock Price Down 5% - Here's WhyJune 3, 2025 | marketbeat.comBTC Capital Management Inc. Makes New $368,000 Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 2, 2025 | marketbeat.comGAMMA Investing LLC Increases Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 2, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New $10.03 Million Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 1, 2025 | marketbeat.comLansforsakringar Fondforvaltning AB publ Invests $426,000 in Halozyme Therapeutics, Inc. (NASDAQ:HALO)May 31, 2025 | marketbeat.comVoloridge Investment Management LLC Invests $876,000 in Halozyme Therapeutics, Inc. (NASDAQ:HALO)May 31, 2025 | marketbeat.comTidal Investments LLC Has $381,000 Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)May 31, 2025 | marketbeat.comH.C. Wainwright Reiterates Buy on Halozyme (HALO), Maintains Price TargetMay 31, 2025 | msn.comHalozyme Therapeutics (NASDAQ:HALO) Receives "Buy" Rating from HC WainwrightMay 30, 2025 | marketbeat.comImplied Volatility Surging for Halozyme Therapeutics Stock OptionsMay 28, 2025 | msn.comHigh Growth Tech Stocks To Watch In The US May 2025May 28, 2025 | uk.finance.yahoo.comWhat's Driving the Market Sentiment Around Halozyme Therapeutics?May 28, 2025 | benzinga.comHalozyme to Participate at Upcoming Investor ConferencesMay 28, 2025 | prnewswire.com Get Halozyme Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Email Address HALO Media Mentions By Week HALO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HALO News Sentiment▼0.620.54▲Average Medical News Sentiment HALO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HALO Articles This Week▼1112▲HALO Articles Average Week Get Halozyme Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BIIB News Today INCY News Today UTHR News Today NBIX News Today EXEL News Today BMRN News Today EXAS News Today RGEN News Today MDGL News Today IONS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HALO) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Halozyme Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
